Blogs

Experience with Generic Pegylated L-asparaginase in Children with Acute Lymphoblastic Leukemia from a Tertiary Care Oncology Center in South India

South Asian J Cancer, 2023 Apr 10;12(4):371-377. doi: 10.1055/s-0042-1759785 https://pubmed.ncbi.nlm.nih.gov/38130281/

Systematic clinical and pharmacological monitoring of a PEG-asparaginase biogeneric (HAMSYL®) in paediatric patients with newly-diagnosed acute lymphoblastic leukaemia

Pediatr Hematol Oncol. 2023; 8(4):S48. doi: 10.1016/j.phoj.2023.10.122 https://www.sciencedirect.com/science/article/pii/S2468124523001821?via%3Dihub

Randomized, Parallel Group, Open-Label Bioequivalence Trial of Intramuscular Pegaspargase in Patients With Relapsed Acute Lymphoblastic Leukemia

JCO Glob Oncol. 2020 Jul;6:1009-1016. doi: 10.1200/GO.20.00113. https://pubmed.ncbi.nlm.nih.gov/32628582/

Establishment of the first international standard for PEGylated granulocyte colony stimulating factor (PEG-G-CSF): Report of an international collaborative study

J Immunol Methods. 2015 Jan;416:17-28. doi: 10.1016/j.jim.2014.10.005. https://www.ncbi.nlm.nih.gov/pubmed/25450254

Assessing analytical comparability of biosimilars: GCSF as a case study

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Oct 1;1032:165-171. doi: 10.1016/j.jchromb.2016.05.027. https://www.ncbi.nlm.nih.gov/pubmed/27289250

Retrospective post-marketing study on the use of bio-similar pegasparagase among acute lymphoblastic leukemia patients in India

Pediatric Hematology Oncology Journal, Volume 3, Issue 1, March 2018, Pages 9-12 https://www.sciencedirect.com/science/article/pii/S2468124517301031

Experience with generic pegylated L-asparaginase in children with acute lymphoblastic leukemia and monitoring of serum asparaginase activity.

Pediatr Hematol Oncol. 2018 Aug – Sep;35(5-6):331-340. doi: 10.1080/08880018.2018.1538277 https://www.ncbi.nlm.nih.gov/pubmed/30488741

Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials.

Am J Cardiovasc Drugs. 2018 Oct;18(5):387-395. doi: 10.1007/s40256-018-0284-1. https://www.ncbi.nlm.nih.gov/pubmed/29948822

Efficacy and safety of tenecteplase in diabetic and non-diabetic patients of STEMI – Indian registry data

J Assoc Physicians India. 2010 Apr;58:229-30. https://www.ncbi.nlm.nih.gov/pubmed/21046876

Tenecteplase in the treatment of acute pulmonary thrombo-embolism.

J Thromb Thrombolysis. 2011 May;31(4):445-8. doi: 10.1007/s11239-010-0524-y. https://www.ncbi.nlm.nih.gov/pubmed/20972606